Brief: Moberg Pharma Q3 EBITDA At SEK 22.7 Mln

Moberg Pharma AB (publ)

06/11/2018 07:10

Nov 6 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q3 NET REVENUE SEK 108.6 MILLION (108.3, CURRENT PORTFOLIO
93.2)
CURRENT PORTFOLIO GROWTH 17%
    * Q3 EBITDA SEK 22.7 MILLION (36.0) INCLUDING, AND SEK 22.7
MILLION (23.0) EXCLUDING, CAPITAL GAINS
    * MOBERG PHARMA > - "I AM VERY PLEASED WITH STRONG
PERFORMANCE AND
CONTINUED MOMENTUM IN OUR COMMERCIAL OPERATIONS" - CEO

Source text for Eikon:  ID:nWkr3fQV2W 
Further company coverage:  MBPH.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))